Q Therapeutics Email Format
Biotechnology ResearchUtah, United States2-10 Employees
In 2018, the company announced a joint research agreement with InVivo Therapeutics to pursue collaborative CNS-focused research. Earlier that year, it partnered with ReproCELL to explore cell and gene therapies targeting demyelinating and degenerative CNS conditions. The firm’s base in Salt Lake City and its small team size place it within a niche of clinical-stage CNS cell therapy development.